These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
302 related items for PubMed ID: 9586913
41. Randomized comparison of etoposide-cisplatin vs. etoposide-carboplatin and irradiation in small-cell lung cancer. A Hellenic Co-operative Oncology Group study. Skarlos DV, Samantas E, Kosmidis P, Fountzilas G, Angelidou M, Palamidas P, Mylonakis N, Provata A, Papadakis E, Klouvas G. Ann Oncol; 1994 Sep; 5(7):601-7. PubMed ID: 7993835 [Abstract] [Full Text] [Related]
42. Dose-intensive weekly chemotherapy for treatment of relapsed small-cell lung cancer. Kubota K, Nishiwaki Y, Kakinuma R, Hojo F, Matsumoto T, Ohmatsu H, Sekine I, Yokozaki M, Goto K, Ebi N, Kodama T. J Clin Oncol; 1997 Jan; 15(1):292-6. PubMed ID: 8996155 [Abstract] [Full Text] [Related]
43. Etoposide-cisplatin and thoracic radiation therapy salvage of incomplete responders to a noncisplatin induction regimen for limited and extensive small-cell carcinoma of the lung. Shaw EG, Frytak S, Eagan RT, Richardson RL, Creagan ET, Jett JR, Foote RL, Su JQ, Schaid DJ, Lee RE. Am J Clin Oncol; 1996 Apr; 19(2):154-8. PubMed ID: 8610640 [Abstract] [Full Text] [Related]
44. Pilot study of concurrent etoposide and cisplatin plus accelerated hyperfractionated thoracic radiotherapy followed by irinotecan and cisplatin for limited-stage small cell lung cancer: Japan Clinical Oncology Group 9903. Kubota K, Nishiwaki Y, Sugiura T, Noda K, Mori K, Kawahara M, Negoro S, Watanabe K, Imamura F, Tamura T, Saijo N. Clin Cancer Res; 2005 Aug 01; 11(15):5534-8. PubMed ID: 16061870 [Abstract] [Full Text] [Related]
45. Cisplatin/etoposide chemotherapy combined with twice daily thoracic radiotherapy for limited small-cell lung cancer: a clinical phase II trial. Chen GY, Jiang GL, Wang LJ, Qian H, Fu XL, Yang H, Wu KL, Zhao S. Int J Radiat Oncol Biol Phys; 2005 Jan 01; 61(1):70-5. PubMed ID: 15629596 [Abstract] [Full Text] [Related]
46. Multicenter phase II trial of paclitaxel, cisplatin, and etoposide with concurrent radiation for limited-stage small-cell lung cancer. Bremnes RM, Sundstrøm S, Vilsvik J, Aasebø U, Norwegian Lung Cancer Study Group. J Clin Oncol; 2001 Aug 01; 19(15):3532-8. PubMed ID: 11481360 [Abstract] [Full Text] [Related]
47. Cisplatin plus etoposide with and without ifosfamide in extensive small-cell lung cancer: a Hoosier Oncology Group study. Loehrer PJ, Ansari R, Gonin R, Monaco F, Fisher W, Sandler A, Einhorn LH. J Clin Oncol; 1995 Oct 01; 13(10):2594-9. PubMed ID: 7595712 [Abstract] [Full Text] [Related]
51. Sequencing and schedule effects of cisplatin plus etoposide in small-cell lung cancer: results of a North Central Cancer Treatment Group randomized clinical trial. Maksymiuk AW, Jett JR, Earle JD, Su JQ, Diegert FA, Mailliard JA, Kardinal CG, Krook JE, Veeder MH, Wiesenfeld M. J Clin Oncol; 1994 Jan 01; 12(1):70-6. PubMed ID: 8270988 [Abstract] [Full Text] [Related]
52. Split-course versus continuous thoracic radiation therapy for limited-stage small-cell lung cancer: final report of a randomized phase III trial. Blackstock AW, Bogart JA, Matthews C, Lovato JF, McCoy T, Livengood K, Ho C, White D, Atkins JN, Miller AA. Clin Lung Cancer; 2005 Mar 01; 6(5):287-92. PubMed ID: 15845179 [Abstract] [Full Text] [Related]
53. Alternating chemotherapy with etoposide plus cisplatin and topotecan plus paclitaxel in patients with untreated, extensive-stage small cell lung carcinoma: a phase II trial of the North Central Cancer Treatment Group. Jett JR, Hatfield AK, Hillman S, Bauman MD, Mailliard JA, Kugler JW, Morton RF, Marks RS, Levitt R. Cancer; 2003 May 15; 97(10):2498-503. PubMed ID: 12733149 [Abstract] [Full Text] [Related]
54. Etoposide/vincristine-based chemotherapy with or without carboplatin in extensive-stage small cell lung cancer: a prospective randomized phase III trial. Gatzemeier U, Pawel JV, Laumen R, Hossfeld DK, Neuhauss R. Semin Oncol; 1994 Jun 15; 21(3 Suppl 6):31-5. PubMed ID: 8052871 [Abstract] [Full Text] [Related]